Cargando…
Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum
BACKGROUND: The aim of the present work was to assess the in vitro cross-resistance of pyronaridine with other quinoline drugs, artesunate and several other commonly used anti-malarials and to evaluate whether decreased susceptibility to pyronaridine could be associated with genetic polymorphisms in...
Autores principales: | Pradines, Bruno, Briolant, Sébastien, Henry, Maud, Oeuvray, Claude, Baret, Eric, Amalvict, Rémy, Didillon, Eric, Rogier, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224917/ https://www.ncbi.nlm.nih.gov/pubmed/21108786 http://dx.doi.org/10.1186/1475-2875-9-339 |
Ejemplares similares
-
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
por: Pascual, Aurélie, et al.
Publicado: (2015) -
The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016) -
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum
por: Parquet, Véronique, et al.
Publicado: (2010) -
In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na(+)/H(+ )exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo
por: Briolant, Sébastien, et al.
Publicado: (2011) -
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum
por: Pascual, Aurélie, et al.
Publicado: (2012)